KEY POINT: There is a correlation between mental health disorders and the risk of developing insomnia and sleep apnea.

The stop-signal task may be valuable for assessing inhibitory control deficits in adult attention-deficit/hyperactivity disorder (ADHD), according to a systematic review and meta-analysis published online June 10 in Neuropsychology Review.

New positive data was recently released from 5 in vitro studies investigating the potential for drug-drug interaction of mazindol.

In this video, Jeremy Faust, MD, editor-in-chief of MedPage Today, sits down with Jessi Gold, MD, an assistant professor in the department of psychiatry at Washington University School of Medicine in St. Louis, and Amanda Calhoun, MD, MPH, a psychiatry resident at the Yale Child Study Center in New Haven, Connecticut, to discuss the nuances…

Experts weigh in on the challenges facing those with ADHD and discuss ways to manage symptoms.

Behind a veneer of accomplishment, underneath good grades and musical talents, Emily Chen was in disarray. She never knew what she was missing, perpetually cycling through potential mistakes in her mind in a desperate attempt not to slip up.

Every October is Attention Deficit Hyperactivity Disorder (ADHD) Awareness Month, an occasion to raise awareness and support for those with ADHD.

Supply of a common Adderall alternative is running low, further limiting options for US patients amid a national shortage of ADHD drugs that has lasted almost a year. Vyvanse, sold by Takeda Pharmaceutical Co., is in low inventory due to manufacturing issues, a company spokesperson told Bloomberg News.

Pavel Tabutov’s family had been invited to a gathering near his Los Angeles exurb home to hear a friend’s daughter perform with her singing group. But it wasn’t a great night to go out. His three young kids were cranky, and it would be a crowded social event where the kids would need to sit…

ADHD is a common mental disorder among children and adolescents. But often symptoms continue into adulthood, where it is underdiagnosed and undertreated. A late-stage diagnosis can be life-changing.

Computerized Progressive Attention Training (CPAT), a new treatment developed at Tel Aviv University, significantly improved the symptoms of 33 percent of students suffering from Attention Deficit Hyperactivity Disorder (ADHD).

CONFERENCE REPORTER: Researchers shared mixed good news for the novel treatment centanafadine for treating attention-deficit/hyperactivity disorder at the American Society of Health-System Pharmacists 2023 Summer Meetings and Exhibition.1 Specifically, they found centanafadine had a better safety profile and demonstrated more favorable tolerability but was less effective than lisdexamfetamine dimesylate (Vyvanse) for adults with ADHD.